Global consulting firm McKinsey & Company agreed Friday to pay $650 million to resolve criminal and civil investigations into the advice it provided to opioids manufacturer Purdue Pharma.

The firm faced charges of conspiracy to defraud the U.S., destroying documents. International consulting firm McKinsey & Company agreed Friday to resolve criminal charges with federal prosecutors ...

Consulting firm McKinsey & Company has agreed to pay $650m to resolve a United States Department of Justice investigation into the consulting firm’s work advising opioid manufacturer Purdue ...

McKinsey enters five-year deferred prosecution agreement Ex-partner Martin Elling to plead guilty to obstruction McKinsey to improve compliance and resolve civil probe BOSTON, Dec 13 (Reuters ...

McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work for opioids manufacturer Purdue Pharma, according to court papers filed in ...

Consulting giant McKinsey & Company will pay $650 million to settle US criminal charges that it collaborated with Purdue Pharma to intentionally misbrand opioids, worsening a public health crisis ...

BOSTON (AP) — McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work to help opioids manufacturer Purdue Pharma boost the sales of the ...

By Walt Bogdanich and Michael Forsythe Walt Bogdanich and Michael Forsythe have reported extensively on McKinsey & Company and written a book on its business dealings. McKinsey & Company has ...

McKinsey said it agreed to accept responsibility for its role in helping Purdue Pharma turbocharge sales of its OxyContin opioid painkiller as the consulting firm entered into a $650 million ...

McKinsey & Company agreed to pay $650 million in a deferred prosecution agreement that will resolve a federal criminal probe into the company’s consulting work advising Purdue Pharma on how ...